{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:47:41Z","timestamp":1793119661019,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010890","name":"Chinese Government Scholarship","doi-asserted-by":"publisher","award":["201506210062"],"award-info":[{"award-number":["201506210062"]}],"id":[{"id":"10.13039\/501100010890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"University of Groningen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD), characterized as excess lipid accumulation in the liver which is not due to alcohol use, has emerged as one of the major health problems around the world. The dysregulated lipid metabolism creates a lipotoxic environment which promotes the development of NAFLD, especially the progression from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purposeand Aim<\/jats:title>\n                    <jats:p>This review focuses on the mechanisms of lipid accumulation in the liver, with an emphasis on the metabolic fate of free fatty acids (FFAs) in NAFLD and presents an update on the relevant cellular processes\/mechanisms that are involved in lipotoxicity. The changes in the levels of various lipid species that result from the imbalance between lipolysis\/lipid uptake\/lipogenesis and lipid oxidation\/secretion can cause organellar dysfunction, e.g. ER stress, mitochondrial dysfunction, lysosomal dysfunction, JNK activation, secretion of extracellular vesicles (EVs) and aggravate (or be exacerbated by) hypoxia which ultimately lead to cell death. The aim of this review is to provide an overview of how abnormal lipid metabolism leads to lipotoxicity and the cellular mechanisms of lipotoxicity in the context of NAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12072-020-10121-2","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T19:32:18Z","timestamp":1612812738000},"page":"21-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":421,"title":["How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-0875","authenticated-orcid":false,"given":"Yana","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas Nico","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent E.","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Blokzijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Moshage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,6]]},"reference":[{"key":"10121_CR1","first-page":"201","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, et al. A new definition for metabolic associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:201.","journal-title":"J Hepatol"},{"issue":"4","key":"10121_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jhep.2017.12.002","volume":"68","author":"CD Byrne","year":"2018","unstructured":"Byrne CD, Perseghin G. Non-alcoholic fatty liver disease: a risk factor for myocardial dysfunction? J Hepatol. 2018;68(4):640\u20132.","journal-title":"J Hepatol"},{"issue":"7","key":"10121_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"10","key":"10121_CR4","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1007\/s10620-017-4684-x","volume":"62","author":"G Cholankeril","year":"2017","unstructured":"Cholankeril G, et al. Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes. Dig Dis Sci. 2017;62(10):2915\u201322.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10121_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/TP.0000000000002484","volume":"103","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, et al. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation. 2019;103(1):22\u20137.","journal-title":"Transplantation"},{"issue":"2","key":"10121_CR6","doi-asserted-by":"publisher","first-page":"e0171502","DOI":"10.1371\/journal.pone.0171502","volume":"12","author":"EH van den Berg","year":"2017","unstructured":"van den Berg EH, et al. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: a large Dutch population cohort. PLoS ONE. 2017;12(2):e0171502.","journal-title":"PLoS ONE"},{"issue":"2","key":"10121_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2017.173","volume":"14","author":"G Targher","year":"2018","unstructured":"Targher G, Lonardo A, Byrne CD. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2018;14(2):99\u2013114.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10121_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61(5):1547\u201354.","journal-title":"Hepatology"},{"key":"10121_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","volume":"13","author":"JP Arab","year":"2018","unstructured":"Arab JP, Arrese M, Trauner M. Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Annu Rev Pathol. 2018;13:321\u201350.","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10121_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","volume":"20","author":"M Schoeler","year":"2019","unstructured":"Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019;20(4):461\u201372.","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"10121_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","volume":"28","author":"S Lang","year":"2020","unstructured":"Lang S, Schnabl B. Microbiota and fatty liver disease-the known, the unknown, and the future. Cell Host Microbe. 2020;28(2):233\u201344.","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10121_CR12","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1136\/gutjnl-2016-312238","volume":"66","author":"P Bedossa","year":"2017","unstructured":"Bedossa P, et al. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity. Gut. 2017;66(9):1688\u201396.","journal-title":"Gut"},{"issue":"1","key":"10121_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1053\/j.gastro.2015.09.003","volume":"150","author":"E Fabbrini","year":"2016","unstructured":"Fabbrini E, et al. Physiological mechanisms of weight gain-induced steatosis in people with obesity. Gastroenterology. 2016;150(1):79\u201381.","journal-title":"Gastroenterology"},{"key":"10121_CR14","doi-asserted-by":"crossref","unstructured":"Cimini FA et al. Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease. Diabetes Metab Res Rev 2020","DOI":"10.1002\/dmrr.3358"},{"issue":"2","key":"10121_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4161\/21623945.2014.978662","volume":"4","author":"CL Gentile","year":"2015","unstructured":"Gentile CL, et al. The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD. Adipocyte. 2015;4(2):101\u201312.","journal-title":"Adipocyte"},{"issue":"5","key":"10121_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Investig. 2005;115(5):1343\u201351.","journal-title":"J Clin Investig"},{"issue":"2","key":"10121_CR17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","volume":"70","author":"RS Khan","year":"2019","unstructured":"Khan RS, et al. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology. 2019;70(2):711\u201324.","journal-title":"Hepatology"},{"issue":"4","key":"10121_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bbalip.2014.09.023","volume":"1851","author":"M Masoodi","year":"2015","unstructured":"Masoodi M, et al. Lipid signaling in adipose tissue: connecting inflammation and metabolism. Biochim Biophys Acta. 2015;1851(4):503\u201318.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10121_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrm.2017.76","volume":"18","author":"R Zechner","year":"2017","unstructured":"Zechner R, Madeo F, Kratky D. Cytosolic lipolysis and lipophagy: two sides of the same coin. Nat Rev Mol Cell Biol. 2017;18(11):671\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10121_CR20","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-16-0513","volume":"234","author":"CE Geisler","year":"2017","unstructured":"Geisler CE, Renquist BJ. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. J Endocrinol. 2017;234(1):R1\u201321.","journal-title":"J Endocrinol"},{"issue":"6","key":"10121_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/dmrr.2312","volume":"28","author":"V Miksztowicz","year":"2012","unstructured":"Miksztowicz V, et al. Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance. Diabetes Metab Res Rev. 2012;28(6):535\u201341.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10121_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00535-019-01633-2","volume":"55","author":"K Enooku","year":"2020","unstructured":"Enooku K, et al. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients. J Gastroenterol. 2020;55(2):227\u201343.","journal-title":"J Gastroenterol"},{"issue":"2","key":"10121_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41419-020-2295-5","volume":"11","author":"M Han","year":"2020","unstructured":"Han M, et al. Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease. Cell Death Dis. 2020;11(2):104.","journal-title":"Cell Death Dis"},{"issue":"6","key":"10121_CR24","doi-asserted-by":"publisher","first-page":"e0178748","DOI":"10.1371\/journal.pone.0178748","volume":"12","author":"M Li","year":"2017","unstructured":"Li M, et al. Caveolin1 protects against diet induced hepatic lipid accumulation in mice. PLoS ONE. 2017;12(6):e0178748.","journal-title":"PLoS ONE"},{"issue":"2","key":"10121_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/en.2015-1866","volume":"157","author":"CG Wilson","year":"2016","unstructured":"Wilson CG, et al. Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-Fed mice. Endocrinology. 2016;157(2):570\u201385.","journal-title":"Endocrinology"},{"issue":"3","key":"10121_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1530\/JOE-15-0219","volume":"227","author":"I Andres-Blasco","year":"2015","unstructured":"Andres-Blasco I, et al. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. J Endocrinol. 2015;227(3):179\u201391.","journal-title":"J Endocrinol"},{"issue":"8","key":"10121_CR27","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/hep4.1383","volume":"3","author":"T Teratani","year":"2019","unstructured":"Teratani T, et al. Lipoprotein lipase up-regulation in hepatic stellate cells exacerbates liver fibrosis in nonalcoholic steatohepatitis in mice. Hepatol Commun. 2019;3(8):1098\u2013112.","journal-title":"Hepatol Commun"},{"issue":"6","key":"10121_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","volume":"7","author":"M Furuhashi","year":"2008","unstructured":"Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7(6):489\u2013503.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10121_CR29","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","volume":"68","author":"T Jensen","year":"2018","unstructured":"Jensen T, et al. Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68(5):1063\u201375.","journal-title":"J Hepatol"},{"issue":"2","key":"10121_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1053\/j.gastro.2018.06.031","volume":"155","author":"G Musso","year":"2018","unstructured":"Musso G, et al. Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis. Gastroenterology. 2018;155(2):282\u2013302.","journal-title":"Gastroenterology"},{"issue":"4","key":"10121_CR31","doi-asserted-by":"publisher","first-page":"046002","DOI":"10.1088\/1752-7163\/aacf12","volume":"12","author":"PR Afolabi","year":"2018","unstructured":"Afolabi PR, et al. The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the (13)C-ketoisocaproate breath test. J Breath Res. 2018;12(4):046002.","journal-title":"J Breath Res"},{"issue":"6","key":"10121_CR32","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"NE Sunny","year":"2011","unstructured":"Sunny NE, et al. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 2011;14(6):804\u201310.","journal-title":"Cell Metab"},{"issue":"1","key":"10121_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2016.06.005","volume":"24","author":"KF Petersen","year":"2016","unstructured":"Petersen KF, et al. Assessment of hepatic mitochondrial oxidation and pyruvate cycling in NAFLD by (13)C magnetic resonance spectroscopy. Cell Metab. 2016;24(1):167\u201371.","journal-title":"Cell Metab"},{"issue":"3","key":"10121_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018;155(3):629\u201347.","journal-title":"Gastroenterology"},{"issue":"6","key":"10121_CR35","doi-asserted-by":"publisher","first-page":"e93626","DOI":"10.1172\/jci.insight.93626","volume":"3","author":"ME Moreno-Fernandez","year":"2018","unstructured":"Moreno-Fernandez ME, et al. Peroxisomal beta-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease. JCI Insight. 2018;3(6):e93626.","journal-title":"JCI Insight"},{"issue":"2","key":"10121_CR36","doi-asserted-by":"publisher","first-page":"E187","DOI":"10.1152\/ajpendo.00425.2012","volume":"304","author":"H Weng","year":"2013","unstructured":"Weng H, et al. Pex11alpha deficiency impairs peroxisome elongation and division and contributes to nonalcoholic fatty liver in mice. Am J Physiol Endocrinol Metab. 2013;304(2):E187\u201396.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10121_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","volume":"134","author":"E Fabbrini","year":"2008","unstructured":"Fabbrini E, et al. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology. 2008;134(2):424\u201331.","journal-title":"Gastroenterology"},{"key":"10121_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2020.02.026","volume":"299","author":"K Konishi","year":"2020","unstructured":"Konishi K, et al. Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. Atherosclerosis. 2020;299:32\u20137.","journal-title":"Atherosclerosis"},{"issue":"6","key":"10121_CR39","first-page":"40","volume":"4","author":"FM Perla","year":"2017","unstructured":"Perla FM, et al. The role of lipid and lipoprotein metabolism in non-alcoholic fatty liver disease. Children (Basel). 2017;4(6):40.","journal-title":"Children (Basel)"},{"key":"10121_CR40","doi-asserted-by":"publisher","first-page":"783976","DOI":"10.1155\/2011\/783976","volume":"2011","author":"K Fon Tacer","year":"2011","unstructured":"Fon Tacer K, Rozman D. Nonalcoholic fatty liver disease: focus on lipoprotein and lipid deregulation. J Lipids. 2011;2011:783976.","journal-title":"J Lipids"},{"issue":"1","key":"10121_CR41","doi-asserted-by":"publisher","first-page":"G75","DOI":"10.1152\/ajpgi.00170.2018","volume":"316","author":"S Liangpunsakul","year":"2019","unstructured":"Liangpunsakul S, Chalasani N. Lipid mediators of liver injury in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2019;316(1):G75\u201381.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"10121_CR42","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","volume":"65","author":"M Mota","year":"2016","unstructured":"Mota M, et al. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1049\u201361.","journal-title":"Metabolism"},{"issue":"4","key":"10121_CR43","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri P, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46(4):1081\u201390.","journal-title":"Hepatology"},{"issue":"3","key":"10121_CR44","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1194\/jlr.P056002","volume":"56","author":"DL Gorden","year":"2015","unstructured":"Gorden DL, et al. Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. J Lipid Res. 2015;56(3):722\u201336.","journal-title":"J Lipid Res"},{"key":"10121_CR45","doi-asserted-by":"publisher","first-page":"46658","DOI":"10.1038\/srep46658","volume":"7","author":"F Chiappini","year":"2017","unstructured":"Chiappini F, et al. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients. Sci Rep. 2017;7:46658.","journal-title":"Sci Rep"},{"issue":"10","key":"10121_CR46","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1194\/jlr.M085613","volume":"59","author":"KY Peng","year":"2018","unstructured":"Peng KY, et al. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression. J Lipid Res. 2018;59(10):1977\u201386.","journal-title":"J Lipid Res"},{"issue":"6","key":"10121_CR47","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/hep.23229","volume":"50","author":"P Puri","year":"2009","unstructured":"Puri P, et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology. 2009;50(6):1827\u201338.","journal-title":"Hepatology"},{"issue":"10","key":"10121_CR48","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","volume":"14","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, et al. Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites. Clin Gastroenterol Hepatol. 2016;14(10):1463\u201372.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10121_CR49","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/nu10050649","volume":"10","author":"S Tiwari-Heckler","year":"2018","unstructured":"Tiwari-Heckler S, et al. Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors. Nutrients. 2018;10(5):649.","journal-title":"Nutrients"},{"issue":"4","key":"10121_CR50","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","volume":"69","author":"C Lebeaupin","year":"2018","unstructured":"Lebeaupin C, et al. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018;69(4):927\u201347.","journal-title":"J Hepatol"},{"issue":"3","key":"10121_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cmet.2015.06.010","volume":"22","author":"AP Arruda","year":"2015","unstructured":"Arruda AP, Hotamisligil GS. Calcium homeostasis and organelle function in the pathogenesis of obesity and diabetes. Cell Metab. 2015;22(3):381\u201397.","journal-title":"Cell Metab"},{"key":"10121_CR52","doi-asserted-by":"publisher","first-page":"e1179","DOI":"10.1038\/cddis.2014.162","volume":"5","author":"A Gonzalez-Rodriguez","year":"2014","unstructured":"Gonzalez-Rodriguez A, et al. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis. 2014;5:e1179.","journal-title":"Cell Death Dis"},{"key":"10121_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmet.2018.10.005","volume":"19","author":"S Lopez-Domenech","year":"2019","unstructured":"Lopez-Domenech S, et al. Moderate weight loss attenuates chronic endoplasmic reticulum stress and mitochondrial dysfunction in human obesity. Mol Metab. 2019;19:24\u201333.","journal-title":"Mol Metab"},{"key":"10121_CR54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.lfs.2018.04.022","volume":"203","author":"X Chen","year":"2018","unstructured":"Chen X, et al. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis. Life Sci. 2018;203:291\u2013304.","journal-title":"Life Sci"},{"issue":"1","key":"10121_CR55","doi-asserted-by":"publisher","first-page":"G77","DOI":"10.1152\/ajpgi.00301.2011","volume":"302","author":"K Kakisaka","year":"2012","unstructured":"Kakisaka K, et al. Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis. Am J Physiol Gastrointest Liver Physiol. 2012;302(1):G77-84.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10121_CR56","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/hepr.12658","volume":"46","author":"Y Akazawa","year":"2016","unstructured":"Akazawa Y, Nakao K. Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors. Hepatol Res. 2016;46(10):977\u201384.","journal-title":"Hepatol Res"},{"issue":"11","key":"10121_CR57","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.2337\/db12-0123","volume":"61","author":"DA Cunha","year":"2012","unstructured":"Cunha DA, et al. Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human beta-cell apoptosis. Diabetes. 2012;61(11):2763\u201375.","journal-title":"Diabetes"},{"key":"10121_CR58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.mce.2015.06.025","volume":"413","author":"JY Chan","year":"2015","unstructured":"Chan JY, et al. The balance between adaptive and apoptotic unfolded protein responses regulates beta-cell death under ER stress conditions through XBP1, CHOP and JNK. Mol Cell Endocrinol. 2015;413:189\u2013201.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10121_CR59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.tem.2019.02.005","volume":"30","author":"ES Ali","year":"2019","unstructured":"Ali ES, Petrovsky N. Calcium signaling as a therapeutic target for liver steatosis. Trends Endocrinol Metab. 2019;30(4):270\u201381.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10121_CR60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tem.2016.01.001","volume":"27","author":"C Piperi","year":"2016","unstructured":"Piperi C, Adamopoulos C, Papavassiliou AG. XBP1: a pivotal transcriptional regulator of glucose and lipid metabolism. Trends Endocrinol Metab. 2016;27(3):119\u201322.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10121_CR61","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.26126","volume":"57","author":"H Jo","year":"2013","unstructured":"Jo H, et al. Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor. Hepatology. 2013;57(4):1366\u201377.","journal-title":"Hepatology"},{"issue":"7","key":"10121_CR62","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.2337\/db15-1637","volume":"65","author":"X Chen","year":"2016","unstructured":"Chen X, et al. Hepatic ATF6 increases fatty acid oxidation to attenuate hepatic steatosis in mice through peroxisome proliferator-activated receptor alpha. Diabetes. 2016;65(7):1904\u201315.","journal-title":"Diabetes"},{"issue":"9","key":"10121_CR63","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.1074\/jbc.M109.056648","volume":"285","author":"B Bailly-Maitre","year":"2010","unstructured":"Bailly-Maitre B, et al. Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance. J Biol Chem. 2010;285(9):6198\u2013207.","journal-title":"J Biol Chem"},{"issue":"5","key":"10121_CR64","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1210\/en.2011-1881","volume":"153","author":"CS Achard","year":"2012","unstructured":"Achard CS, Laybutt DR. Lipid-induced endoplasmic reticulum stress in liver cells results in two distinct outcomes: adaptation with enhanced insulin signaling or insulin resistance. Endocrinology. 2012;153(5):2164\u201377.","journal-title":"Endocrinology"},{"issue":"9","key":"10121_CR65","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/gutjnl-2012-302962","volume":"62","author":"CJ Pirola","year":"2013","unstructured":"Pirola CJ, et al. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut. 2013;62(9):1356\u201363.","journal-title":"Gut"},{"key":"10121_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2017.08.015","volume":"40","author":"C Einer","year":"2018","unstructured":"Einer C, et al. Mitochondrial adaptation in steatotic mice. Mitochondrion. 2018;40:1\u201312.","journal-title":"Mitochondrion"},{"issue":"2","key":"10121_CR67","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.metabol.2013.10.009","volume":"63","author":"RA Egnatchik","year":"2014","unstructured":"Egnatchik RA, et al. Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes. Metabolism. 2014;63(2):283\u201395.","journal-title":"Metabolism"},{"issue":"6","key":"10121_CR68","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.dld.2020.03.021","volume":"52","author":"Y Gao","year":"2020","unstructured":"Gao Y, et al. Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis. Dig Liver Dis. 2020;52(6):637\u201343.","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10121_CR69","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/hep.29689","volume":"67","author":"S Win","year":"2018","unstructured":"Win S, et al. New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases. Hepatology. 2018;67(5):2013\u201324.","journal-title":"Hepatology"},{"issue":"5","key":"10121_CR70","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.22183","volume":"47","author":"Z Li","year":"2008","unstructured":"Li Z, et al. The lysosomal\u2013mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology. 2008;47(5):1495\u2013503.","journal-title":"Hepatology"},{"issue":"1","key":"10121_CR71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.20283","volume":"40","author":"AE Feldstein","year":"2004","unstructured":"Feldstein AE, et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology. 2004;40(1):185\u201394.","journal-title":"Hepatology"},{"issue":"6","key":"10121_CR72","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3390\/ijms18061134","volume":"18","author":"F Tovoli","year":"2017","unstructured":"Tovoli F, et al. A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease. Int J Mol Sci. 2017;18(6):1134.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10121_CR73","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.ebiom.2015.05.018","volume":"2","author":"F Baratta","year":"2015","unstructured":"Baratta F, et al. Reduced lysosomal acid lipase activity in adult patients with non-alcoholic fatty liver disease. EBioMedicine. 2015;2(7):750\u20134.","journal-title":"EBioMedicine"},{"issue":"8","key":"10121_CR74","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.dld.2016.04.014","volume":"48","author":"PK Selvakumar","year":"2016","unstructured":"Selvakumar PK, et al. Reduced lysosomal acid lipase activity\u2014a potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients. Dig Liver Dis. 2016;48(8):909\u201313.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10121_CR75","doi-asserted-by":"publisher","first-page":"e20160214","DOI":"10.1542\/peds.2016-0214","volume":"138","author":"RW Himes","year":"2016","unstructured":"Himes RW, et al. Lysosomal acid lipase deficiency unmasked in two children with nonalcoholic fatty liver disease. Pediatrics. 2016;138(4):e20160214.","journal-title":"Pediatrics"},{"issue":"1","key":"10121_CR76","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1096\/fj.201601393R","volume":"32","author":"X Wang","year":"2018","unstructured":"Wang X, et al. Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis. FASEB J. 2018;32(1):37\u201351.","journal-title":"FASEB J"},{"issue":"11","key":"10121_CR77","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1194\/jlr.M600329-JLR200","volume":"47","author":"SC Schweitzer","year":"2006","unstructured":"Schweitzer SC, et al. Endogenous versus exogenous fatty acid availability affects lysosomal acidity and MHC class II expression. J Lipid Res. 2006;47(11):2525\u201337.","journal-title":"J Lipid Res"},{"issue":"10","key":"10121_CR78","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1194\/jlr.R066357","volume":"57","author":"P Hirsova","year":"2016","unstructured":"Hirsova P, et al. Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis. J Lipid Res. 2016;57(10):1758\u201370.","journal-title":"J Lipid Res"},{"issue":"1","key":"10121_CR79","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41418-019-0356-z","volume":"27","author":"T Zhang","year":"2020","unstructured":"Zhang T, et al. SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity. Cell Death Differ. 2020;27(1):329\u201344.","journal-title":"Cell Death Differ"},{"issue":"7","key":"10121_CR80","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.ajpath.2016.03.003","volume":"186","author":"K Miyagawa","year":"2016","unstructured":"Miyagawa K, et al. Lipid-induced endoplasmic reticulum stress impairs selective autophagy at the step of autophagosome\u2013lysosome fusion in hepatocytes. Am J Pathol. 2016;186(7):1861\u201373.","journal-title":"Am J Pathol"},{"issue":"5","key":"10121_CR81","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","volume":"70","author":"M Allaire","year":"2019","unstructured":"Allaire M, et al. Autophagy in liver diseases: time for translation? J Hepatol. 2019;70(5):985\u201398.","journal-title":"J Hepatol"},{"issue":"1","key":"10121_CR82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hep.22578","volume":"49","author":"R Singh","year":"2009","unstructured":"Singh R, et al. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology. 2009;49(1):87\u201396.","journal-title":"Hepatology"},{"issue":"2","key":"10121_CR83","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1113\/JP271457","volume":"594","author":"M Pal","year":"2016","unstructured":"Pal M, Febbraio MA, Lancaster GI. The roles of c-Jun NH2-terminal kinases (JNKs) in obesity and insulin resistance. J Physiol. 2016;594(2):267\u201379.","journal-title":"J Physiol"},{"key":"10121_CR84","doi-asserted-by":"publisher","first-page":"e2096","DOI":"10.1038\/cddis.2016.19","volume":"7","author":"MV Machado","year":"2016","unstructured":"Machado MV, et al. Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease. Cell Death Dis. 2016;7:e2096.","journal-title":"Cell Death Dis"},{"issue":"7","key":"10121_CR85","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1136\/gutjnl-2014-307362","volume":"64","author":"MV Machado","year":"2015","unstructured":"Machado MV, et al. Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. Gut. 2015;64(7):1148\u201357.","journal-title":"Gut"},{"issue":"6","key":"10121_CR86","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41418-018-0111-x","volume":"25","author":"CH Wilson","year":"2018","unstructured":"Wilson CH, Kumar S. Caspases in metabolic disease and their therapeutic potential. Cell Death Differ. 2018;25(6):1010\u201324.","journal-title":"Cell Death Differ"},{"issue":"4","key":"10121_CR87","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jhep.2012.05.011","volume":"57","author":"K Kakisaka","year":"2012","unstructured":"Kakisaka K, et al. A hedgehog survival pathway in \u201cundead\u201d lipotoxic hepatocytes. J Hepatol. 2012;57(4):844\u201351.","journal-title":"J Hepatol"},{"issue":"1","key":"10121_CR88","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jcmgh.2014.11.005","volume":"1","author":"P Hirsova","year":"2015","unstructured":"Hirsova P, Gores GJ. Death receptor-mediated cell death and proinflammatory signaling in nonalcoholic steatohepatitis. Cell Mol Gastroenterol Hepatol. 2015;1(1):17\u201327.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"10121_CR89","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jhep.2014.11.033","volume":"62","author":"L Idrissova","year":"2015","unstructured":"Idrissova L, et al. TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess. J Hepatol. 2015;62(5):1156\u201363.","journal-title":"J Hepatol"},{"issue":"12","key":"10121_CR90","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","volume":"15","author":"RF Schwabe","year":"2018","unstructured":"Schwabe RF, Luedde T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol. 2018;15(12):738\u201352.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10121_CR91","doi-asserted-by":"publisher","first-page":"16089","DOI":"10.1038\/cddiscovery.2016.89","volume":"2","author":"L Dara","year":"2016","unstructured":"Dara L, Liu ZX, Kaplowitz N. Questions and controversies: the role of necroptosis in liver disease. Cell Death Discov. 2016;2:16089.","journal-title":"Cell Death Discov"},{"issue":"5","key":"10121_CR92","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/hep.28700","volume":"64","author":"L Dara","year":"2016","unstructured":"Dara L, Kaplowitz N. The many faces of RIPK3: what about NASH? Hepatology. 2016;64(5):1411\u20133.","journal-title":"Hepatology"},{"issue":"2","key":"10121_CR93","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/cvr\/cvu146","volume":"103","author":"M Luedde","year":"2014","unstructured":"Luedde M, et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res. 2014;103(2):206\u201316.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10121_CR94","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/CS20140732","volume":"129","author":"MB Afonso","year":"2015","unstructured":"Afonso MB, et al. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Clin Sci (Lond). 2015;129(8):721\u201339.","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10121_CR95","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2019.11.008","volume":"72","author":"A Majdi","year":"2020","unstructured":"Majdi A, et al. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease. J Hepatol. 2020;72(4):627\u201335.","journal-title":"J Hepatol"},{"issue":"3","key":"10121_CR96","doi-asserted-by":"publisher","first-page":"165621","DOI":"10.1016\/j.bbadis.2019.165621","volume":"1866","author":"Y Geng","year":"2020","unstructured":"Geng Y, et al. Protective effect of metformin against palmitate-induced hepatic cell death. Biochim Biophys Acta Mol Basis Dis. 2020;1866(3):165621.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5","key":"10121_CR97","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.28676","volume":"64","author":"S Roychowdhury","year":"2016","unstructured":"Roychowdhury S, et al. Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury. Hepatology. 2016;64(5):1518\u201333.","journal-title":"Hepatology"},{"issue":"4","key":"10121_CR98","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jhep.2018.01.017","volume":"68","author":"JI Beier","year":"2018","unstructured":"Beier JI, Banales JM. Pyroptosis: an inflammatory link between NAFLD and NASH with potential therapeutic implications. J Hepatol. 2018;68(4):643\u20135.","journal-title":"J Hepatol"},{"key":"10121_CR99","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jhep.2020.04.001","volume":"73","author":"J Gautheron","year":"2020","unstructured":"Gautheron J, Gores GJ, Rodrigues CMP. Lytic cell death in metabolic liver disease. J Hepatol. 2020;73:394.","journal-title":"J Hepatol"},{"issue":"1","key":"10121_CR100","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.24341","volume":"54","author":"T Csak","year":"2011","unstructured":"Csak T, et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology. 2011;54(1):133\u201344.","journal-title":"Hepatology"},{"issue":"6","key":"10121_CR101","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41374-018-0177-6","volume":"99","author":"NP Zhang","year":"2019","unstructured":"Zhang NP, et al. Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. Lab Investig. 2019;99(6):749\u201363.","journal-title":"Lab Investig"},{"issue":"1","key":"10121_CR102","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1038\/s41598-017-03675-z","volume":"7","author":"D Cabrera","year":"2017","unstructured":"Cabrera D, et al. Andrographolide ameliorates inflammation and fibrogenesis and attenuates inflammasome activation in experimental non-alcoholic steatohepatitis. Sci Rep. 2017;7(1):3491.","journal-title":"Sci Rep"},{"issue":"4","key":"10121_CR103","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/cells9040817","volume":"9","author":"A Hernandez","year":"2020","unstructured":"Hernandez A, et al. Extracellular vesicles in NAFLD\/ALD: from pathobiology to therapy. Cells. 2020;9(4):817.","journal-title":"Cells"},{"issue":"4","key":"10121_CR104","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2015.12.037","volume":"150","author":"P Hirsova","year":"2016","unstructured":"Hirsova P, et al. Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes. Gastroenterology. 2016;150(4):956\u201367.","journal-title":"Gastroenterology"},{"issue":"1","key":"10121_CR105","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1038\/s41598-017-03389-2","volume":"7","author":"YS Lee","year":"2017","unstructured":"Lee YS, et al. Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. Sci Rep. 2017;7(1):3710.","journal-title":"Sci Rep"},{"issue":"2","key":"10121_CR106","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1194\/jlr.M063412","volume":"57","author":"E Kakazu","year":"2016","unstructured":"Kakazu E, et al. Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1alpha-dependent manner. J Lipid Res. 2016;57(2):233\u201345.","journal-title":"J Lipid Res"},{"issue":"3","key":"10121_CR107","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/hep.28252","volume":"63","author":"SH Ibrahim","year":"2016","unstructured":"Ibrahim SH, et al. Mixed lineage kinase 3 mediates release of C\u2013X\u2013C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. Hepatology. 2016;63(3):731\u201344.","journal-title":"Hepatology"},{"issue":"3","key":"10121_CR108","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jhep.2016.04.010","volume":"65","author":"SS Sundaram","year":"2016","unstructured":"Sundaram SS, et al. Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease. J Hepatol. 2016;65(3):560\u20139.","journal-title":"J Hepatol"},{"issue":"7","key":"10121_CR109","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1164\/rccm.201806-1109TR","volume":"199","author":"OA Mesarwi","year":"2019","unstructured":"Mesarwi OA, Loomba R, Malhotra A. Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease. Am J Respir Crit Care Med. 2019;199(7):830\u201341.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10121_CR110","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1183\/13993003.01923-2016","volume":"49","author":"D Viglino","year":"2017","unstructured":"Viglino D, et al. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. Eur Respir J. 2017;49(6):160.","journal-title":"Eur Respir J"},{"key":"10121_CR111","doi-asserted-by":"publisher","first-page":"165753","DOI":"10.1016\/j.bbadis.2020.165753","volume":"1866","author":"A Hernandez","year":"2020","unstructured":"Hernandez A, et al. Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165753.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"10121_CR112","doi-asserted-by":"publisher","first-page":"165753","DOI":"10.1016\/j.bbadis.2020.165753","volume":"1866","author":"A Hernandez","year":"2020","unstructured":"Hernandez A, et al. Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles. Biochim Biophys Acta Mol Basis Dis. 2020;1866(6):165753.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10121_CR113","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jss.2007.12.784","volume":"152","author":"F Berthiaume","year":"2009","unstructured":"Berthiaume F, et al. Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury. J Surg Res. 2009;152(1):54\u201360.","journal-title":"J Surg Res"},{"issue":"6","key":"10121_CR114","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/hep.29754","volume":"67","author":"E Morello","year":"2018","unstructured":"Morello E, et al. Hypoxia-inducible factor 2alpha drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein. Hepatology. 2018;67(6):2196\u2013214.","journal-title":"Hepatology"},{"issue":"1","key":"10121_CR115","doi-asserted-by":"publisher","first-page":"14230","DOI":"10.1038\/s41598-018-32586-w","volume":"8","author":"T Arai","year":"2018","unstructured":"Arai T, Tanaka M, Goda N. HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver. Sci Rep. 2018;8(1):14230.","journal-title":"Sci Rep"},{"key":"10121_CR116","doi-asserted-by":"crossref","unstructured":"Vadarlis A et al. Systematic review with meta-analysis: the effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2020","DOI":"10.1111\/jgh.15221"},{"key":"10121_CR117","doi-asserted-by":"publisher","first-page":"115183","DOI":"10.1016\/j.taap.2020.115183","volume":"404","author":"Y Geng","year":"2020","unstructured":"Geng Y, et al. Hesperetin protects against palmitate-induced cellular toxicity via induction of GRP78 in hepatocytes. Toxicol Appl Pharmacol. 2020;404:115183.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"10121_CR118","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1194\/jlr.R067595","volume":"57","author":"J Han","year":"2016","unstructured":"Han J, Kaufman RJ. The role of ER stress in lipid metabolism and lipotoxicity. J Lipid Res. 2016;57(8):1329\u201338.","journal-title":"J Lipid Res"},{"issue":"2","key":"10121_CR119","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jcmgh.2019.04.007","volume":"8","author":"WP Esler","year":"2019","unstructured":"Esler WP, Bence KK. Metabolic targets in nonalcoholic fatty liver disease. Cell Mol Gastroenterol Hepatol. 2019;8(2):247\u201367.","journal-title":"Cell Mol Gastroenterol Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10121-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-020-10121-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10121-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T14:38:08Z","timestamp":1697812688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-020-10121-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10121"],"URL":"https:\/\/doi.org\/10.1007\/s12072-020-10121-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"3 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any direct studies with animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal research (ethics)"}},{"value":"None declared. All the authors have seen and approved the submission of this version of the manuscript and take full responsibility for the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish (ethics)"}},{"value":"This article does not contain any direct studies with human subjects.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trials registration"}}]}}